Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Non-Current Debt (2018 - 2025)

Historic Non-Current Debt for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to $22.3 million.

  • Exagen's Non-Current Debt rose 1229.88% to $22.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.3 million, marking a year-over-year increase of 1229.88%. This contributed to the annual value of $19.8 million for FY2024, which is 307.32% up from last year.
  • Exagen's Non-Current Debt amounted to $22.3 million in Q3 2025, which was up 1229.88% from $22.3 million recorded in Q2 2025.
  • Over the past 5 years, Exagen's Non-Current Debt peaked at $29.1 million during Q1 2023, and registered a low of $18.4 million during Q1 2025.
  • Moreover, its 5-year median value for Non-Current Debt was $22.3 million (2025), whereas its average is $23.7 million.
  • Its Non-Current Debt has fluctuated over the past 5 years, first tumbled by 3376.53% in 2024, then skyrocketed by 1250.63% in 2025.
  • Over the past 5 years, Exagen's Non-Current Debt (Quarter) stood at $27.5 million in 2021, then rose by 4.73% to $28.8 million in 2022, then tumbled by 33.17% to $19.2 million in 2023, then grew by 3.07% to $19.8 million in 2024, then increased by 12.3% to $22.3 million in 2025.
  • Its last three reported values are $22.3 million in Q3 2025, $22.3 million for Q2 2025, and $18.4 million during Q1 2025.